Live feed
Filing
SC 13G/A
SC 13G/A0001437749-17-002399·Schemel Donald Robert
Schedule 13G ownership disclosure
Sun BioPharma, Inc.
Security class unavailable · CUSIP: 86664M107
Event date: 2016-12-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 11.8000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001437749-17-002399
- Form type
- SC 13G/A
- Filer
- Schemel Donald Robert
- CIK
- CIK 1652854
- Filed
- Feb 14, 2017
- Reporting period
- Dec 31, 2016
- Description
- Schedule 13G beneficial ownership